Ray Therapeutics

Ray Therapeutics is a clinical-stage biotechnology company developing optogenetic, gene-based medicines to restore vision in people with blinding degenerative retinal diseases. Its approach reprograms surviving retinal neurons to detect light and transmit visual signals to the brain, independent of the underlying gene mutation. Lead programs include RTX-015 (retinitis pigmentosa and other inherited retinal diseases, Phase 1/2) and RTX-021 (Stargardt disease and geographic atrophy, IND-enabling). The company is a portfolio company of Norwest Venture Partners. Ray Therapeutics operates as a therapeutics developer and does not publish a public developer API, documentation, or developer portal.

Ray Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Therapy, Optogenetics, and Ophthalmology.

🌐 Visit website 📡 Source on GitHub
11.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyGene TherapyOptogeneticsOphthalmologyVision RestorationRetinal DiseaseClinical Stage

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.0/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/raytherapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Raytherapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService
TermsOfService
 PrivacyPolicy
PrivacyPolicy

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: raytherapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/raytherapeutics.png
name: Ray Therapeutics
description: Ray Therapeutics is a clinical-stage biotechnology company developing optogenetic, gene-based medicines to restore
  vision in people with blinding degenerative retinal diseases. Its approach reprograms surviving retinal neurons to detect
  light and transmit visual signals to the brain, independent of the underlying gene mutation. Lead programs include RTX-015
  (retinitis pigmentosa and other inherited retinal diseases, Phase 1/2) and RTX-021 (Stargardt disease and geographic atrophy,
  IND-enabling). The company is a portfolio company of Norwest Venture Partners. Ray Therapeutics operates as a therapeutics
  developer and does not publish a public developer API, documentation, or developer portal.
url: https://raw.githubusercontent.com/api-evangelist/raytherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- norwest-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Gene Therapy
- Optogenetics
- Ophthalmology
- Vision Restoration
- Retinal Disease
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://raytherapeutics.com
- type: TermsOfService
  url: https://raytherapeutics.com/terms-of-use/
- type: PrivacyPolicy
  url: https://raytherapeutics.com/privacy-policy/
- type: DomainSecurity
  url: security/raytherapeutics-domain-security.yml
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1